Lung Cancer Trials Ask AI to find trials
Active Not RecruitingNot applicableNCT06685133
Official study title

Prospective Evaluation of the Tool-in-lesion Technology of the Galaxy System in Routine Clinical Practice

Study summary

A prospective observational study evaluating the accuracy of the tool-in-lesion technology of the Galaxy SystemTM in normal clinical practice.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedRobotic assisted bronchoscopy

The study team can explain what participation involves.

Who it may be forLung Cancer · Lung; Nodule

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 15, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Not applicable

Observational

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?Noah Medical

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Noah Medical
Interventions being studied
Device: Robotic assisted bronchoscopy
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Age ≥ 18 2. Patients with indeterminate lung nodule 3. Peripheral pulmonary subsolid and solid nodules (PPNs) sized up to 3 cm measured as the largest dimension based on the pre-procedural CT 4. Pre-procedural CT is conducted within 90 days of the bronchoscopy procedure 5. Informed consent properly obtained per local regulations

Reasons someone may not be able to joinExclusion criteria

1. Known pregnancy or breastfeeding 2. Patients with pure ground-glass nodules on pre-procedural chest CT 3. Uncontrolled coagulopathy or bleeding disorders 4. Ongoing systemic infection 5. History of lobectomy or pneumonectomy 6. Patients with pacemakers or defibrillators 7. Unsuitable for bronchoscopy procedure under general anesthesia as agreed by the treating clinician and anesthetist 8. Patients with pleural effusion or diaphragmatic paralysis

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • CHI Memorial HospitalChattanooga, Tennessee
  • Inova Fairfax Medical CampusFalls Church, Virginia

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 15, 2025. Always confirm current availability with the study team.

View original record ↗